The Silvacx Team is a well balanced mixture of industrial experience, academic know-how and entrepreneuership.
Current team members:
- Armin Kübelbeck, Dipl.-Ing.; Head of Silvacx Project
- Agnieszka Grabowska, PhD; Principal Scientist; Vaccine Development
- Armin Götzke, PhD; IP & Regulatory Affairs
- Thomas Kessler, Dipl.-Ing. (Chemistry), Dipl.-Betriebswirt; Business Development
Silvacx's Scientific Advisory Board
- Prof. Dr. Gert Fricker
Head of Dept. Pharmaceutical Technology and Biopharmacy at the Institute of Pharmacy and Molecular Biotechnology at Heidelberg University. - Prof. Dr. Walter Mier
Head of Radiopharmaceutical Chemistry, University Hospital Heidelberg.
Co-founder Antiinfektiva GmbH. - PD Dr. Dr. Angelika Riemer
Head of Division Immunotherapy and Immunoprevention, German Cancer Research Center (DKFZ), Heidelberg - Dr. Michael Wolf, former Head Immunoncolgy at Merck KGaA (Darmstadt).
Cooperation Partners
- German Cancer Research Center (DKFZ) in Heidelberg
- Ottawa Hospital Research Institute (OHRI), Ottawa, Canada
- National Health Institute (NIH), Bethesda, MD, United Staates